Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marni Stott-Miller

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology and Therapeutics|November 24, 2021
Integration of Real-World Data and Genetics to Support Target Identification and ValidationJonathan M Davitte, Marni Stott-Miller, Margaret G Ehm, et al.
The Journal of Rheumatology|January 17, 2018
Association Between Glucocorticoid Exposure and Healthcare Expenditures for Potential Glucocorticoid-related Adverse Events in Patients with Rheumatoid ArthritisJennie H Best, Amanda M Kong, Gregory M Lenhart, et al.
Journal of Pediatric Psychology|June 11, 2009
Reading in children with orofacial clefts versus controlsBrent R Collett, Marni Stott-Miller, Kathleen A Kapp-Simon, et al.
The Prostate|November 7, 2012
HOXB13 mutations in a population-based, case-control study of prostate cancerMarni Stott-Miller, Danielle M Karyadi, Tiffany Smith, et al.
Cancer Causes & Control : CCC|September 27, 2012
A history of allergies is associated with reduced risk of oral squamous cell carcinomaMarni Stott-Miller, Chu Chen, David R Doody, et al.
Lupus Science & Medicine|April 29, 2020
Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USAChristopher F Bell, Julie Priest, Marni Stott-Miller, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2011
Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinomaMarni Stott-Miller, John R Houck, Pawadee Lohavanichbutr, et al.
Pediatrics|February 17, 2010
Case-control study of neurodevelopment in deformational plagiocephalyMatthew L Speltz, Brent R Collett, Marni Stott-Miller, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 11, 2014
Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrenceMarni Stott-Miller, Shanshan Zhao, Jonathan L Wright, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 9, 2013
Germline missense variants in the BTNL2 gene are associated with prostate cancer susceptibilityLiesel M Fitzgerald, Akash Kumar, Evan A Boyle, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|November 24, 2021
Integration of Real-World Data and Genetics to Support Target Identification and ValidationJonathan M Davitte, Marni Stott-Miller, Margaret G Ehm, et al.
The Journal of Rheumatology|January 17, 2018
Association Between Glucocorticoid Exposure and Healthcare Expenditures for Potential Glucocorticoid-related Adverse Events in Patients with Rheumatoid ArthritisJennie H Best, Amanda M Kong, Gregory M Lenhart, et al.
Journal of Pediatric Psychology|June 11, 2009
Reading in children with orofacial clefts versus controlsBrent R Collett, Marni Stott-Miller, Kathleen A Kapp-Simon, et al.
The Prostate|November 7, 2012
HOXB13 mutations in a population-based, case-control study of prostate cancerMarni Stott-Miller, Danielle M Karyadi, Tiffany Smith, et al.
Cancer Causes & Control : CCC|September 27, 2012
A history of allergies is associated with reduced risk of oral squamous cell carcinomaMarni Stott-Miller, Chu Chen, David R Doody, et al.
Lupus Science & Medicine|April 29, 2020
Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USAChristopher F Bell, Julie Priest, Marni Stott-Miller, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2011
Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinomaMarni Stott-Miller, John R Houck, Pawadee Lohavanichbutr, et al.
Pediatrics|February 17, 2010
Case-control study of neurodevelopment in deformational plagiocephalyMatthew L Speltz, Brent R Collett, Marni Stott-Miller, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 11, 2014
Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrenceMarni Stott-Miller, Shanshan Zhao, Jonathan L Wright, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 9, 2013
Germline missense variants in the BTNL2 gene are associated with prostate cancer susceptibilityLiesel M Fitzgerald, Akash Kumar, Evan A Boyle, et al.
Pageof 3